The IPKat previously reported (here)
the High
Court decision in Blue Gentian v Tristar Products; a decision perhaps most
notable for its brevity. The recent Court of Appeal decision (here) in the
same case is even shorter, concluding that Birss J “carried out a thorough
evaluation of the evidence before him and … made careful findings. He has made
no error of principle. In my judgment there is no basis for this court to
interfere with the conclusions to which he has come”, and unanimously upholding
the patent for the XHose
expandable hose. This might be some consolation to Mr Justice Birss,
having recently been told by the Court of Appeal that he had misinterpreted the
meaning of the number 1 (see the IPKat's posts here and here)!
In the first instance in this case, Tristar did not contest that their actions would infringe the patent were it to be valid, but alleged that it was invalid because it lacked novelty or was obvious in the light of two prior art publications. On appeal, novelty was not at issue, with Tristar only arguing that Birss J had erred when assessing inventive step.
It is established UK law that inventive step is “a kind of jury question” and that “where the application of a legal standard such as… obviousness involves no question of principle but is simply a matter of degree, an appellate court should be very cautious in differing from the judge’s evaluation” (Lord Hoffman in Biogen v Medeva UKHL). In this case, Tristar argued that Birss had indeed made a fundamental error in approaching the allegations of obviousness in that:
Perhaps more interesting is that the patent has fared differently in litigation in different jurisdictions; the Court of Appeal in Canada rejected an appeal from the judgment of Mr Justice Hughes who had found the patent obvious over the same prior art before Birss J (first instance here and appeal here). In Australia the patent had been found valid (see here) and the judgment from the Australian Court of Appeal is awaited.
In the first instance in this case, Tristar did not contest that their actions would infringe the patent were it to be valid, but alleged that it was invalid because it lacked novelty or was obvious in the light of two prior art publications. On appeal, novelty was not at issue, with Tristar only arguing that Birss J had erred when assessing inventive step.
It is established UK law that inventive step is “a kind of jury question” and that “where the application of a legal standard such as… obviousness involves no question of principle but is simply a matter of degree, an appellate court should be very cautious in differing from the judge’s evaluation” (Lord Hoffman in Biogen v Medeva UKHL). In this case, Tristar argued that Birss had indeed made a fundamental error in approaching the allegations of obviousness in that:
i) in relation to the first prior art document, he wrongly construed the document and that his errors of construction led him to conclude, wrongly, that their obviousness attack should be rejected as reliant upon hindsight; and
Merpel's distrust of hosepipes is not unfounded
ii) in relation to the second, he again wrongly construed the document and relied upon evidence from Blue Gentian's expert, Mr Sinclair, which he should not have accepted.Whilst mis-construction of a prior art document is of course a principle in which one could err, and despite the fact that Tristar made submissions which were “attractively…developed” by their counsel, Lord Justice Kitchin, (Lord Justice Tomlinson and Lady Justice Hallett concurring) found in Blue Gentian’s favour. The Court of Appeal found that Birss J's analysis of the prior art and his reliance on the expert evidence was factually and legally sound and affirmed the High Court decision.
Perhaps more interesting is that the patent has fared differently in litigation in different jurisdictions; the Court of Appeal in Canada rejected an appeal from the judgment of Mr Justice Hughes who had found the patent obvious over the same prior art before Birss J (first instance here and appeal here). In Australia the patent had been found valid (see here) and the judgment from the Australian Court of Appeal is awaited.
Hosepipe Ban to Continue - Blue Gentian patent upheld in appeal
Reviewed by Darren Smyth
on
Thursday, July 23, 2015
Rating:
No comments:
All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.
It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.
Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html